Committed to improving the lives of patients with respiratory conditions

We’re a biopharmaceutical company developing innovative prescription medicines.

Our Vision

Meeting unmet medical needs

Our goal is to improve the lives of those affected by the burden of chronic respiratory diseases. We are committed to delivering our treatments to the millions of patients suffering from respiratory diseases as quickly as possible.

Meeting unmet medical needs

Our Strategy

Agile and flexible approach

We are focused on developing ensifentrine, which we believe has the potential to become an important and novel treatment for lung diseases.

Agile and flexible approach

Company Leadership

We expect 2024 to be a transformational year for Verona Pharma. We are finalizing our US launch preparations and look forward to commercializing ensifentrine in the second half of this year, if approved. We will also continue to progress our development programs to build-out our pipeline.


Hiring outstanding individuals

We are expanding rapidly and seeking exceptional people to join our team. Explore career opportunities at Verona.

Corporate Governance
Corporate Governance

Verona’s Board of Directors sets high standards for our employees, officers and directors and good corporate governance is implicit in these values. Learn more here.

Developing novel therapeutics for respiratory diseases

To learn more about Verona Pharma, please get in touch.